ArticleFrontiers in pharmacology2026

Comparative post-marketing reporting signals of elagolix and myfembree in endometriosis: a FAERS pharmacovigilance study.

MengLong Bai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.